IDO1 and liver dysplastic nodule: Additionally, indoleamine 2,3-dioxygenase 1 (IDO1), lymphocyte-specific protein tyrosine kinase (LCK), and hematopoietic cell kinase (HCK) have been identified as novel immune-related markers in DN patients (16, 17).